Potential Application of the Myocardial Scintigraphy Agent [123I]BMIPP in Colon Cancer Cell Imaging
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25147747 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kakeru Sato und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Health Sciences, Graduate School of Medical Sciences, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa 920-0942, Japan. Hauptthemen laut MEDLINE: Colonic Neoplasms, Iodobenzenes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaken Pharmaceutical (Japan), The Network-type Joint Usage/Research Center for Radiation Disaster Medical Science, Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.
Abstract (Originalsprache)
[123I]β-methyl-p-iodophenyl-pentadecanoic acid ([123I]BMIPP), which is used for nuclear medicine imaging of myocardial fatty acid metabolism, accumulates in cancer cells. However, the mechanism of accumulation remains unknown. Therefore, this study aimed to elucidate the accumulation and accumulation mechanism of [123I]BMIPP in cancer cells. We compared the accumulation of [123I]BMIPP in cancer cells with that of [18F]FDG and found that [123I]BMIPP was a much higher accumulation than [18F]FDG. The accumulation of [123I]BMIPP was evaluated in the presence of sulfosuccinimidyl oleate (SSO), a CD36 inhibitor, and lipofermata, a fatty acid transport protein (FATP) inhibitor, under low-temperature conditions and in the presence of etomoxir, a carnitine palmitoyl transferase I (CPT1) inhibitor. The results showed that [123I]BMIPP accumulation was decreased in the presence of SSO and lipofermata in H441, LS180, and DLD-1 cells, suggesting that FATPs and CD36 are involved in [123I]BMIPP uptake in cancer cells. [123I]BMIPP accumulation in all cancer cell lines was significantly decreased at 4 °C compared to that at 37 °C and increased in the presence of etomoxir in all cancer cell lines, suggesting that the accumulation of [123I]BMIPP in cancer cells is metabolically dependent. In a biological distribution study conducted using tumor-bearing mice transplanted with LS180 cells, [123I]BMIPP highly accumulated in not only LS180 cells but also normal tissues and organs (including blood and muscle). The tumor-to-intestine or large intestine ratios of [123I]BMIPP were similar to those of [18F]FDG, and the tumor-to-large-intestine ratios exceeded 1.0 during 30 min after [123I]BMIPP administration in the in vivo study. [123I]BMIPP is taken up by cancer cells via CD36 and FATP and incorporated into mitochondria via CPT1. Therefore, [123I]BMIPP may be useful for imaging cancers with activated fatty acid metabolism, such as colon cancer. However, the development of novel imaging radiotracers based on the chemical structure analog of [123I]BMIPP is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Health Sciences, Graduate School of Medical Sciences, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa 920-0942, Japan.
- Radiological Center, University of Fukui Hospital, 23-3 Matsuokashimoaizuki, Eiheiji, Fukui 910-1193, Japan.
- Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa 920-0942, Japan.
- Research Team for Neuroimaging, Tokyo Metropolitan Institute for Geriatrics and Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan.
- Department of Radiological Technology, Faculty of Health Science, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
- Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
ORCID-Profile: Jianwei Yao, Kana Yamazaki, Masato Kobayashi
Förderung
- Kaken Pharmaceutical (Japan)
- The Network-type Joint Usage/Research Center for Radiation Disaster Medical Science
- Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science
- Network-type Joint Usage/Research Center for Radiation Disaster Medical Science
Zitieren
APA
Sato, K., Hirayama, Y., Mizutani, A., Yao, J., Higashino, J., Kamitaka, Y., Muranaka, Y., Yamazaki, K., Nishii, R., Kobayashi, M., & Kawai, K. (2024). Potential Application of the Myocardial Scintigraphy Agent [123I]BMIPP in Colon Cancer Cell Imaging. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147747
Vancouver
Sato K, Hirayama Y, Mizutani A, Yao J, Higashino J, Kamitaka Y, et al. Potential Application of the Myocardial Scintigraphy Agent [123I]BMIPP in Colon Cancer Cell Imaging. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147747
BibTeX
@article{Sato2024,
author = {Sato, Kakeru and Hirayama, Yuka and Mizutani, Asuka and Yao, Jianwei and Higashino, Jinya and Kamitaka, Yuto and Muranaka, Yuka and Yamazaki, Kana and Nishii, Ryuichi and Kobayashi, Masato and Kawai, Keiichi},
title = {Potential Application of the Myocardial Scintigraphy Agent [123I]BMIPP in Colon Cancer Cell Imaging},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25147747}
}
EUVIMED